Skip to content

Clinical trials

Phase 2 Acute Kidney Injury trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Kidney Injury Phase: Phase 2 Country / region: United States Clear all

54 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20063
20081
20091
20101
20111
20121
20134
20141
20152
20162
20172
20191
20204
20215
20224
20234
20243
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated11
Recruiting10
Unknown status3
Withdrawn3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Brigham and Women's Hospital2
Mayo Clinic2
Novartis Pharmaceuticals2
RenaMed Biologics2
The University of Texas Health Science Center, Houston2
Westat2
AM-Pharma1
Action Pharma A/S1
AlloCure Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Kidney Injury54
Sepsis4
COVID-193
Reperfusion Injury3
Fibrosis2
Hemorrhage2
Hepatorenal Syndrome2
Renal Insufficiency2
Respiratory Distress Syndrome2
Shock, Septic2

Trials

Showing 1 to 25 of 54. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.